Loading...
Loading...
India's insulin imports from CHINA total $31.1B across 83 shipments from 15 foreign suppliers. GAN & LEE PHARMACEUTICALS leads with $30.7B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include LUPIN LIMITED. This corridor reflects India's pharmaceutical import demand for insulin โ a diversified sourcing base with multiple active suppliers from CHINA.

GAN & LEE PHARMACEUTICALS is the leading Insulin supplier from CHINA to India, with import value of $30.7B across 13 shipments. The top 5 suppliers โ GAN & LEE PHARMACEUTICALS, GAN LEE PHARMACEUTICALS, SHENZHEN YHLO BIOTECH CO., LTD, GENSCRIPT BIOTECH (SINGAPORE), DONGBAO IMPORT AND EXPORT TRADING ( โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GAN & LEE PHARMACEUTICALS | $30.7B | 13 | 98.6% |
| 2 |
| GAN LEE PHARMACEUTICALS |
| $451.0M |
| 5 |
| 1.4% |
| 3 | SHENZHEN YHLO BIOTECH CO., LTD | $2.5K | 8 | 0.0% |
| 4 | GENSCRIPT BIOTECH (SINGAPORE) | $2.0K | 1 | 0.0% |
| 5 | DONGBAO IMPORT AND EXPORT TRADING ( | $1.9K | 1 | 0.0% |
| 6 | SINO BIOLOGICAL INC | $1.9K | 6 | 0.0% |
| 7 | ABBKINE SCIENTIFIC CO.LTD. | $1.8K | 1 | 0.0% |
| 8 | SHENZHEN MICROPROFIT BIOTECH CO.LTD | $1.6K | 2 | 0.0% |
| 9 | SHENZHEN MICROPROFIT BIOTECH CO LTD | $1.3K | 2 | 0.0% |
| 10 | ABBKINE SCIENTIFIC CO. LTD. | $1.3K | 7 | 0.0% |
| 11 | SENBT CO., LTD | $1.2K | 7 | 0.0% |
| 12 | JIAXING KORAIN BIOTECH CO. LTD. | $965 | 4 | 0.0% |
| 13 | WUHAN HUAMEI BIOTECH CO LIMITED | $776 | 1 | 0.0% |
| 14 | SINO BIOLOGICAL INC. | $542 | 3 | 0.0% |
| 15 | SHENZHEN NEW INDUSTRIES BIOMEDICAL | $540 | 2 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | LUPIN LIMITED | $31.1B | 14 | 100.0% |
| 2 | LUPIN LTD | $303.8K | 2 | 0.0% |
| 3 | MANKIND PHARMA LIMITED | $6.7K | 2 | 0.0% |
| 4 | TCM LIMITED | $2.9K | 4 | 0.0% |
| 5 | CPC DIAGNOSTICS PRIVATE LIMITED | $2.8K | 11 | 0.0% |
| 6 | KRISHGEN BIOSYSTEMS | $2.5K | 9 | 0.0% |
| 7 | IMPERIAL LIFE SCIENCES PRIVATE LIMITED | $2.0K | 1 | 0.0% |
| 8 | AMPLICON BIOTECH | $2.0K | 15 | 0.0% |
| 9 | M. J. BIOPHARM PRIVATE LIMITED | $1.9K | 1 | 0.0% |
| 10 | SAIKRIPA ENTERPRISES | $1.8K | 1 | 0.0% |
| 11 | IMMUNOSCIENCE INDIA PRIVATE LIMITED | $1.5K | 7 | 0.0% |
| 12 | BIOCHAIN INCORPORATED | $776 | 1 | 0.0% |
| 13 | PROGENBIOLAB TECHNOLOGIES PRIVATE LIMITED | $543 | 1 | 0.0% |
| 14 | VECTOR BIOTEK PRIVATE LIMITED | $540 | 2 | 0.0% |
| 15 | IMMUNOCONCEPT INDIA PRIVATE LIMITED | $220 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Insulin suppliers from CHINA to India include GAN & LEE PHARMACEUTICALS, GAN LEE PHARMACEUTICALS, SHENZHEN YHLO BIOTECH CO., LTD. The leading supplier is GAN & LEE PHARMACEUTICALS with import value of $30.7B USD across 13 shipments. India imported Insulin worth $31.1B USD from CHINA in total across 83 shipments.
India imported Insulin worth $31.1B USD from CHINA across 83 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Insulin sourced from CHINA include LUPIN LIMITED, LUPIN LTD, MANKIND PHARMA LIMITED. The largest buyer is LUPIN LIMITED with $31.1B in imports across 14 shipments.
The total value of Insulin imports from CHINA to India is $31.1B USD, across 83 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
83 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists